It has, thus, been hypothesised that activation of NF-κB by the classical IKK-dependent pathway is a crucial mediator of inflammation-induced tumour growth and progression, as well as an important modulator of tumour surveillance and rejection (Karin and Greten, 2005). The gene discussed is NFKB1; the disease is neoplasm.